Overactive bladder (OAB) doesn’t directly cause urinary tract infections, but it does increase your risk of getting one. Women diagnosed with OAB are roughly 6 to 17 percent likely to have a UTI at any given time, compared to just 0.5 to 2 percent of women without OAB. The relationship between the two conditions runs in both directions: OAB can set the stage for infection, and infection can trigger or worsen OAB symptoms.
How OAB Raises Your UTI Risk
OAB involves involuntary bladder muscle contractions that create urgency, frequency, and sometimes leakage. These dysfunctional contractions can prevent the bladder from emptying completely. When urine sits in the bladder longer than it should, bacteria have more time to multiply and establish an infection. This leftover urine, called urinary retention, is one of the most well-understood risk factors for UTIs in general.
There’s also a less obvious factor: changes in the bacterial environment inside the bladder. People with more severe OAB symptoms tend to have a different mix of bacteria in their urine compared to those with mild symptoms. Specifically, protective bacteria like Lactobacillus are less common in people with OAB. Lactobacillus helps keep harmful bacteria in check, and women who have lower levels of it are more likely to develop UTIs. Meanwhile, other bacterial types that correlate with inflammation tend to be more abundant as OAB symptoms worsen.
Why the Two Conditions Are Easy to Confuse
OAB and UTIs share their most noticeable symptoms: urgency, frequent urination, and the feeling that you need to go right now. This overlap makes it surprisingly easy for one condition to be mistaken for the other. The key difference is pain. UTIs typically cause burning during urination and sometimes pelvic pain, while OAB generally does not, though about a third of OAB patients do report discomfort when the bladder fills. If your main experience is frequent, hard-to-control urges without burning or pain, OAB is more likely. If burning is prominent, infection is the stronger suspect.
This distinction matters because the treatments are completely different. Antibiotics clear a UTI but do nothing for OAB. And OAB medications won’t resolve an active infection. Getting the wrong diagnosis means your symptoms persist while the actual problem goes untreated.
Hidden Infections Behind an OAB Diagnosis
One of the more striking findings in recent research is how often low-grade infections hide behind what looks like OAB. Standard urine cultures use a relatively high threshold for calling a result “positive.” When researchers used more sensitive testing methods on people already diagnosed with OAB, the picture changed dramatically. In one study, the proportion of OAB patients testing positive for bacteria jumped from 17 percent to 39 percent when the detection threshold was lowered, compared to just 2 to 6 percent of healthy controls.
Advanced techniques that examine bladder tissue and shed cells directly have found bacteria in OAB patients that never showed up on routine urine tests at all. This suggests that a meaningful number of people being treated for OAB actually have a chronic, low-level infection driving their symptoms. When those infections are treated with antibiotics, OAB symptoms often improve significantly. Inflammation from infection increases levels of nerve growth factor in the bladder, which heightens nerve sensitivity and can produce the urgency and frequency characteristic of OAB.
If you’ve been treated for OAB and your symptoms haven’t responded well to standard therapies, an undetected low-grade UTI is worth exploring with your provider. More sensitive urine testing or checking for white blood cells in the urine can help uncover infections that standard cultures miss.
OAB Treatments That Increase UTI Risk
Some treatments for OAB can actually make UTIs more likely, which creates a frustrating cycle. The most notable example is botulinum toxin (Botox) injections into the bladder wall. Botox works by calming overactive bladder muscles, but it can calm them too much, leading to incomplete emptying. In a multicenter study of 278 patients receiving their first Botox treatment for OAB, 22 percent developed at least one UTI within six months. About 18 percent experienced incomplete bladder emptying, which is the mechanism behind the increased infection risk. Some patients in that situation need to use a catheter temporarily, which itself introduces bacteria.
Large clinical trials have consistently reported UTI rates of 15 to 20 percent after Botox injections, and some earlier studies found rates as high as 44 percent. This doesn’t mean Botox is a bad option for OAB. For many people, the symptom relief is significant. But the UTI risk is real and should factor into the decision, especially if you’re already prone to infections.
The other main class of OAB medications, anticholinergics, can also contribute to urinary retention in some patients by reducing the bladder’s ability to contract during urination. The effect is usually mild, but for people who already have some degree of incomplete emptying, it can tip the balance toward bacterial growth.
Breaking the OAB-UTI Cycle
The relationship between OAB and UTIs can become circular. OAB creates conditions favorable for infection, infection inflames the bladder and worsens OAB symptoms, and more severe OAB symptoms further increase infection risk. Breaking this cycle usually requires addressing both sides.
Behavioral strategies are a practical starting point. Timed voiding, where you urinate on a schedule rather than waiting for urgency, helps keep the bladder from overfilling. Pelvic floor exercises can improve your ability to empty the bladder more completely. Staying well hydrated dilutes urine and promotes more frequent flushing of bacteria. These approaches carry no infection risk of their own and are recommended as the first line of OAB management.
If you’re experiencing frequent UTIs alongside OAB symptoms, it’s worth questioning whether both diagnoses are accurate. You may have OAB that predisposes you to infections. You may have recurring low-grade infections that mimic OAB. Or you may have both simultaneously. The answer shapes the treatment approach, and getting it right can mean the difference between years of managed symptoms and actually resolving the problem.